Obesity independently predicts responders to biphasic insulin 50/50 (Humalog Mix50 and Insuman Comb 50) following conversion from other insulin regimens: a retrospective cohort study-Reference-Cited by-同舟云学术

Obesity independently predicts responders to biphasic insulin 50/50 (Humalog Mix50 and Insuman Comb 50) following conversion from other insulin regimens: a retrospective cohort study

Published:2014-05 Issue:1 Volume:2 Page:e000021
ISSN:2052-4897
Container-title:BMJ Open Diabetes Research & Care
language:en
Short-container-title:BMJ Open Diab Res Care

Author:

Mamza J,Mehta R,Idris I

Publisher

BMJ

Subject

Endocrinology, Diabetes and Metabolism

Reference25 articles.

1. Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus;Raccah;Diabetes Obes Metab,2008

2. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group;Turner;JAMA,1999

3. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes;Nathan;Diabetologia,2006

4. National Institute for Health and Clinical Excellence. Type 2 diabetes: newer agents 2009 [cited 19 Jul 2013]. http://www.nice.org.uk/nicemedia/live/12165/44318/44318.pdf

5. Three-year efficacy of complex insulin regimens in type 2 diabetes;Holman;N Engl J Med,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of current trends and recent development in insulin therapy for management of diabetes mellitus;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2017-12

2. Association between insulin-induced weight change and CVD mortality: Evidence from a historic cohort study of 18,814 patients in UK primary care;Diabetes/Metabolism Research and Reviews;2017-10-19

3. Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes;Heart;2016-05-23

4. Clinical use and efficacy of biphasic insulin lispro 50/50 in people with insulin treated diabetes – a nationwide evaluation of clinical practice;Current Medical Research and Opinion;2015-02-09